Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2004-003215-22Phase 4Active
Phase 4, randomised, double-blind trial in Vitiligo comparing Tacalcitol (Bonalfa) arm with Placebo arm (2 arms). Primary endpoint: Primary efficacy endpoint. Started Nov 2005; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2004-003215-22.